ILMN vs LH: fair value comparison
Illumina, Inc. and Labcorp Holdings Inc. · Updated 2026-08-31
Both currently screen as overvalued on TickrTrends' Forward Fair Value model. Within Healthcare, LH currently sits closer to the top of our discount ranking.
| ILMN | LH | |
|---|---|---|
| Verdict | Overvalued | Overvalued |
| Last price | $198.16 | $335.11 |
| 12-month range | $97.82–$198.16 | $251.66–$309.20 |
| Sector rank | #98 of 113 Healthcare | #97 of 113 Healthcare |
| Quality grade | C | C |
| Momentum grade | — | B |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: ILMN fair value analysis · LH fair value analysis